GIONCO DAVID (Chief Accounting Officer) sold 2.7% of their position (9.15K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $58.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/28/2020ACC: 0001104659-20-027399
Officer· Chief Accounting Officer
Since Feb 2019
-9.15K
Net shares
Net seller
$58.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.15K
Price / share
$6.43
Trade value
$58.82K
% of position
2.7%
2/25/2020
342.74K→333.59K
Total
Net shares
−9.15K
Net value
-$58.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2020 | S · Sale | −9.15K | $6.43 | $58.82K | 2.7% | 342.74K | 333.59K |
| Total | −9.15K | -$58.82K | ||||||
Derivative Transactions0
No derivative transactions reported